In vitro susceptibility of multidrug-resistant enterobacteriaceae clinical isolates to tigecycline

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 11, 2012, Pages 2696-2699

  Huang, Te Din ^a   Berhin, Catherine ^a   Bogaerts, P ^a   Glupczynski, Y ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Broth microdilution; Carbapenemases; ESBLs; EUCAST; Vitek 2

Indexed keywords

TIGECYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BELGIUM; BROTH DILUTION; CITROBACTER KOSERI; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; IN VITRO STUDY; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANT ENTEROBACTERIACEAE; NONHUMAN; SERRATIA MARCESCENS;

ANTI-BACTERIAL AGENTS; BELGIUM; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTER; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; HOSPITALS; HUMANS; KLEBSIELLA; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE;

EID: 84867618288     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks288     Document Type: Article

References (11)

1. Doan TL, Fung HB, Mehta D et al. Tigecycline: a glycylcycline antimicrobial agent. Clin Ther 2006; 28: 1079-106.
2. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-first Informational Supplement, M100-S21.
3. Papaparaskevas J, Tzouvelekis LS, Tsakris A et al. In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints. Diagn Microbiol Infect Dis 2010; 66: 187-94.
4. Pillar CM, Draghi DC, Dowzicky MJ et al. In vitro activity of tigecycline against Gram-positive and Gram-negative pathogens as evaluated by broth microdilution and Etest. J Clin Microbiol 2008; 46: 2862-7.
5. Epidemiology of ESBL-producing Enterobacteriaceae extended-spectrum β-lactamases in Belgian hospitals: results of nationwide multicentre survey in 2010. Abstracts of the Twenty-second European Congress of Clinical Microbiology and Infectious Diseases, London
6. Endimiani A, Hujer AM, Hujer KM et al. Evaluation of a commercial microarray system for detection of SHV-, TEM-, CTX-M-, and KPC-type β-lactamase genes in Gram-negative isolates. J Clin Microbiol 2010; 48: 2618-22.
7. Cohen Stuart J, Mouton JW, Diederen BM et al. Evaluation of Etest to determine tigecycline MICs for Enterobacter species. Antimicrob Agents Chemother 2010; 54: 2746-7.
8. Liu JW, Ko WC, Huang CH et al. Agreement assessment of tigecycline susceptibilities determined by the disk diffusion and broth microdilution methods among commonly encountered resistant bacterial isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2008 to 2010. Antimicrob Agents Chemother 2012; 56: 1414-7.
9. Rodriguez-Villalobos H, Bogaerts P, Berhin C et al. Trends in production of extended-spectrum β-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals. J Antimicrob Chemother 2010; 66: 37-47.
10. Livermore DM, Warner M, Mushtaq S et al. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents 2011; 37: 415-9.